Public procurement notice: Prior Information Notice Without Call For Competition
Published: 2019-08-29
Buyer: NHS Wales Informatics Service as hosted by Velindre NHS Trust
Country: UK
Contract type: Supplies
CPV classification: 48000000 | 48180000 | 48517000 | 72212180 | 72260000: Software-related services
Estimated value: 2300000 GBP

Technical requirements: NWIS are looking to procure an all Wales (SACT) ePrescribing Solution. SACT encompasses both biological therapy and cytotoxic chemotherapy (a group of medicines containing chemicals directly toxic to cells preventing their replication or growth). SACT, including chemotherapy, has been provided in the NHS for decades but no national recording of treatment has previously existed, this is therefore a new approach to service delivery. NWIS will be hosting a supplier engagement day on 10.10.2019, the agenda will be confirmed in due course, allowing NWIS to engage with the market and understand what products/solutions are now available. We anticipate the day to include an NWIS overview of the requirements, followed by breakout sessions with individual suppliers to discuss their specific solutions. Following the day, NWIS will develop a scoping document that will be issued to suppliers requesting them to respond with indicative costs that will be used to inform our business case.
This is an All Wales solution and will be deployed across multiple sites within NHS Wales. For full site details please see II.2.14) Additional Information below.
NWIS is looking to procure an all Wales SACT ePrescribing Solution, for a period of a 10+ years. The rational for this is as follows:
Currently across Wales there is a single system supplier but there are varying instances of the e prescribing system. With an All Wales we are seeking to deliver:
— standardise the data collection across Wales and mandate a Systemic Anti-Cancer Treatment (SACT) dataset,
— improve resource allocation across each health board to reduce duplication and improve efficiencies,
— minimise variation in treatments across Wales by providing all Wales evidence based treatment protocols and regimens,
— support more effective use and preparation of high cost drugs including reducing wastage, missed opportunities for collaborative preparation for SACT treatments,
— develop national reporting to support national benchmarking, audit, patient access and rebate schemes and also to support improved procurement of high cost drugs,
— improve patient safety particularly where the management of cancer patients crosses organisational boundaries.
NHS Wales organisations or any successors in exercising their functions, as may be determined by Welsh Ministers) likely to participate in this interim agreement are:
Velindre University NHS Trust, NHS Wales Health Collaborative hosted by Public Health Wales, Betsi Cadwaldr UHB, Cardiff and Vale UHB, Aneurin Bevan UHB, Hywel Dda UHB, Swansea Bay UHB, Cwm Taf Morgannwg UHB, Powys THB.
NWIS are intending potential bidders are invited to a supplier engagement day on 10.10.2019, in the Life Sciences Hub Wales, 3 Assembly Square, Cardiff Bay, CF10 4PL.
If you are interested in attending the event please email laura.panes@wales.nhs.uk by 12.00 noon on 27.9.2019, any emails received after the deadline will not be accepted. Suppliers will also be able to request to book an individual slot to demonstrate their solutions to NHS Wales. An agenda will be confirmed in due course and issued to all suppliers attending the day.


Award value: 2300000